Latest Stock Split Details
Key information about PharmaCyte Biotech, Inc.'s most recent stock split
Developer API
Get PMCB split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1550.00 times fewer shares (a 1:1550 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of PharmaCyte Biotech, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2021-07-12 | 1:1550 | Yes | $0.01 | $0.00 |
| 2003-12-08 | 3:1 | No | N/A | N/A |
About PharmaCyte Biotech, Inc.
Company overview and industry information
PharmaCyte Biotech, Inc. (PMCB) operates in the Biotechnology industry. The recent 1-for-1550 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.